論文

査読有り 国際誌
2020年9月

Antitumor Effects and Tumor-specificity of Guaiazulene-3-Carboxylate Derivatives Against Oral Squamous Cell Carcinoma In Vitro.

Anticancer research
  • Michito Teratani
  • Shouta Nakamura
  • Hiroshi Sakagami
  • Masakazu Fujise
  • Masashi Hashimoto
  • Noriyuki Okudaira
  • Kenjiro Bandow
  • Yosuke Iijima
  • Junko Nagai
  • Yoshihiro Uesawa
  • Hidetsugu Wakabayashi
  • 全て表示

40
9
開始ページ
4885
終了ページ
4894
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.21873/anticanres.14491

AIM: The aim of this study was to investigate the antitumor potential of guaiazulene-3-carboxylate derivatives against oral malignant cells. MATERIALS AND METHODS: Twelve guaiazulene-3-carboxylate derivatives were synthesized by introduction of either with alkyl group [1-5], alkoxy group [6, 7], hydroxyl group [8, 9] or primary amine [10-12] at the end of sidechains. Tumor-specificity (TS) was calculated by the ratio of mean 50% cytotoxic concentration (CC50) against 3 human oral mesenchymal cell lines to that against 4 human oral squamous cell carcinoma (OSCC) cell lines. Potency-selectivity expression (PSE) was calculated by dividing TS value by CC50value against OSCC cell lines. Cell cycle analysis was performed by cell sorter. RESULTS: [6, 7] showed the highest TS and PSE values, and induced the accumulation of both subG1 and G2/M cell populations in HSC-2 OSCC cells. Quantitative structure-activity relationship analysis demonstrated that their tumor-specificity was correlated with chemical descriptors that explain the 3D shape, electric state and ionization potential. CONCLUSION: Alkoxyl guaiazulene-3-carboxylates [6, 7] can be potential candidates of lead compound for developing novel anticancer drugs.

リンク情報
DOI
https://doi.org/10.21873/anticanres.14491
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32878776
ID情報
  • DOI : 10.21873/anticanres.14491
  • PubMed ID : 32878776

エクスポート
BibTeX RIS